Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Gynecol Oncol. 2020 Jan 2;156(3):552–560. doi: 10.1016/j.ygyno.2019.12.015

Fig. 2.

Fig. 2.

Targetable events in mucinous ovarian cancer. A. Genetic events potentially targetable in MOC. MBT = mucinous borderline tumor n = 27, G1 MOC n = 83, G2 MOC n = 78, G3 MOC n = 24. Mutation type: Amp = Amplification (ERBB2 only); HomDel = Homozygous deletion (CDKN2A only). B. ER immunohistochemistry status by MOC grade. C. ERBB2 amplification and HER2 immunohistochemistry. Case 15417 showing concordance of 3+ staining and high-level amplification (Scale bar 100 μm). Case IC392 showing HER2 heterogeneity (Scale bar 200 μm). Arrows indicate location of ERBB2 gene. D. Percentage of cases with the number of genes (from A) affected by mutation or copy number.